For instance, a six-month PPT1 mimetic treatment significantly reduced microglial activation in Ppt1−/− mice, a model of Infantile Neuronal Ceroid Lipofuscinosis (45). The gene discussed is PPT1; the disease is infantile neuronal ceroid lipofuscinosis.